DMS IMAGING S.A.
European Medical Solutions engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium. It offers R/F solutions, including PLATINUM NEO, a smart solution that revolutionizes the R/F workflow, as well as OPTIMA dRF, a robust solution; bone densitometry and body composition analysis equipment; chest and bone rooms, such as … Read more
DMS IMAGING S.A. (AS0) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, DMS IMAGING S.A. (AS0) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
DMS IMAGING S.A. - Net Assets Trend (None–None)
This chart illustrates how DMS IMAGING S.A.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for DMS IMAGING S.A. (None–None)
The table below shows the annual net assets of DMS IMAGING S.A. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to DMS IMAGING S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
DMS IMAGING S.A. Competitors by Market Cap
The table below lists competitors of DMS IMAGING S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MCB GROUP LIMITED
SEM:MCBG
|
$82.58K |
|
ENERGY RECOVERY (5E2.SG)
STU:5E2
|
$82.63K |
|
SuperX AI Technology Limited
NASDAQ:SUPX
|
$82.68K |
|
PETR3F
SA:PETR3F
|
$82.76K |
|
ASAHI GROUP HD - Dusseldorf Stock Exchang
DU:ABW
|
$82.41K |
|
Ilshin Spinning Co. Ltd.
KQ:003200
|
$82.37K |
|
TRIPADVISOR (T6A.SG)
STU:T6A
|
$82.36K |
|
Horizon Space Acquisition I Corp. Warrant
NASDAQ:HSPOW
|
$82.32K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in DMS IMAGING S.A.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares DMS IMAGING S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently DMS IMAGING S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares DMS IMAGING S.A.'s net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $1,345,847,517
- Average return on equity (ROE) among peers: -601.64%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| DMS IMAGING S.A. (AS0) | €- | N/A | N/A | $82.53K |
| 09R (09R) | $5.86 Million | -145.33% | 0.68x | $12.96 Million |
| IDORSIA AG (19T) | $104.20 Million | -608.99% | 13.23x | $582.75 Million |
| 1S90 (1S90) | $10.78 Million | -2319.92% | 31.35x | $54.21 Million |
| Strategic Partners A/S (1TB0) | $14.24 Million | -182.90% | 0.36x | $1.28 Million |
| 25K0 (25K0) | $-79.67 Million | 0.00% | 0.00x | $102.39 Million |
| 2BO (2BO) | $508.00K | -2193.11% | 12.24x | $9.80 Million |
| Intervacc AB (publ) (2E9) | $308.25 Million | -9.53% | 0.07x | $3.46 Million |
| 2F5 (2F5) | $-4.57 Million | 0.00% | 0.00x | $2.14 Million |
| 2H0 (2H0) | $3.03 Million | -558.03% | 2.82x | $9.20 Million |
| GNI Group Ltd (3G6) | $13.10 Billion | 1.39% | 0.57x | $772.60 Million |